TXA2 synthesis and COX1-independent platelet reactivity in aspirin-treated patients soon after acute cerebral stroke or transient ischaemic attack

Thrombosis Research

Volumn 132, Issue 2, 2013, Pages 211-216

  Valles, Juana ^a   Lago, Aida ^a   Moscardo, Antonio ^a   I tembl, Jose ^a   Parkhutik, Vera ^a   Santos, Maria T ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

A2; Acute stroke; Aspirin; Cyclooxygenase 1; Platelet erythrocyte interactions; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; THROMBOXANE A2; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS1 PROTEIN, HUMAN;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SYNTHESIS; ERYTHROCYTE; FEMALE; HEMATOCRIT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PLATELET REACTIVITY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; TRANSIENT ISCHEMIC ATTACK; ACUTE DISEASE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CYCLOOXYGENASE-1; DRUG EFFECT; ENZYMOLOGY; PLATELET-ERYTHROCYTE INTERACTIONS; THROMBOCYTE AGGREGATION; THROMBOXANE A(2);

ACUTE STROKE; ASPIRIN; CYCLOOXYGENASE-1; PLATELET-ERYTHROCYTE INTERACTIONS; THROMBOXANE A(2);

ACUTE DISEASE; AGED; ASPIRIN; CASE-CONTROL STUDIES; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; PLATELET AGGREGATION; STROKE; THROMBOXANE A2;

EID: 84883808803     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.06.010     Document Type: Article

References (39)

1. G. Davi, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
2. Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Br Med J 324 2002 71 86
3. N. Zimmermann, and T. Hohlfeld Clinical implications of aspirin resistance Thromb Haemost 100 2008 379 390
4. T. Hohlfeld Variable platelet response to aspirin in patients with ischemic stroke Cerebrovasc Dis 24 2007 43 50
5. S. Richard, M. Toussaint-Hacquard, R. Fay, J.C. Lacour, X. Ducrocq, and T. Lecompte Laboratory effect on platelet activity within 24 h of the first 300-mg oral dose of aspirin given in hospital during the acute phase of ischemic cerebral events Cerebrovasc Dis 33 2012 574 578
6. P.J. Koudstaal, G. Ciabattoni, J. Vangijn, H.K. Nieuwenhuis, P.G. Degroot, and J.J. Sixma Increased thromboxane biosynthesis in patients with acute cerebral ischemia Stroke 24 1993 219 223
7. F. Van Kooten, G. Ciabattoni, C. Patrono, D.W.J. Dippel, and P.J. Koudstaal Platelet activation and lipid peroxidation in patients with acute ischemic stroke Stroke 28 1997 1557 1563
8. M. Brambilla, A. Parolari, M. Camera, S. Colli, S. Eligini, and C. Centenaro Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery Thromb Haemost 103 2010 516 524
9. M.T. Santos, J. Valles, J. Aznar, A.J. Marcus, M.J. Broekman, and L.B. Safier Prothrombotic effects of erythrocytes on platelet reactivity:Reduction by aspirin Circulation 95 1997 63 68
10. J. Valles, M.T. Santos, J. Aznar, A. Osa, A. Lago, and J. Cosin Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity Circulation 97 1998 350 355
11. M.T. Santos, J. Valles, J. Aznar, A. Lago, E. Sanchez, and J. Cosin Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease J Lab Clin Med 147 2006 220 227
12. 2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease J Thromb Haemost 6 2008 615 621
13. H.P. Adams Jr., P.H. Davis, E.C. Leira, K.C. Chang, B.H. Bendixen, and W.R. Clarke Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Neurology 53 1999 126 131
14. J.L. Banks, and C.A. Marotta Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis Stroke 38 2007 1091 1096
15. M.T. Santos, J. Valles, A.J. Marcus, L.B. Safier, M.J. Broekman, and N. Islam Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment J Clin Invest 87 1991 571 580
16. J. Valles, M.T. Santos, M.P. Fuset, A. Moscardo, M. Ruano, and F. Perez Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction Am J Cardiol 99 2007 19 25
17. M.T. Santos, M.P. Fuset, M. Ruano, A. Moscardo, and J. Valles Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction Am J Cardiol 104 2009 1618 1623
18. U. Fischer, M. Arnold, K. Nedeltchev, C. Brekenfeld, P. Ballinari, and L. Remonda NIHSS score and arteriographic findings in acute ischemic stroke Stroke 36 2005 2121 2125
19. F.M. Pulcinelli, S. Riondino, A. Celestini, P. Pignatelli, E. Trifiro, and L. Di Renzo Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin J Thromb Haemost 3 2005 2784 2789
20. A.O. Maree, R.J. Curtin, M. Dooley, R.M. Conroy, P. Crean, and D. Cox Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease J Am Coll Cardiol 46 2005 1258 1263
21. A.L. Frelinger, Y. Li, M.D. Linden, M.R. Barnard, M.L. Fox, and D.J. Christie Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization Circulation 120 2009 2586 2596
22. H.K. Yip, C.W. Liou, H.W. Chang, M.Y. Lan, J.S. Liu, and M.C. Chen Link between platelet activity and outcomes after an ischemic stroke Cerebrovasc Dis 20 2005 120 128
23. A.L. Frelinger, Y. Li, M.D. Linden, I. Tarnow, M.R. Barnard, and M.L. Fox Aspirin 'resistance': role of pre-existent platelet reactivity and correlation between tests J Thromb Haemost 6 2008 2035 2044
24. A. Moscardo, M.T. Santos, M.P. Fuset, M. Ruano, and J. Valles Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction Thromb Haemost 105 2011 663 669
25. L. Vila, A. Martinez-Perez, M. Camacho, A. Buil, S. Alcolea, and N. Pujol-Moix Heritability of thromboxane A2 and prostaglandin E2 biosynthetic machinery in a Spanish population Arterioscler Thromb Vasc Biol 30 2010 128 134
26. A.O. Maree, R.J. Curtin, A. Chubb, C. Dolan, D. Cox, and J. O'Brien Cyclooxygenase-1 haplotype modulates platelet response to aspirin J Thromb Haemost 3 2005 2340 2345
27. J.D. Snoep, M.M. Hovens, J.C. Eikenboom, J.G. van der Bom, and M.V. Huisman Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis Arch Intern Med 167 2007 1593 1599
28. G. Krasopoulos, S.J. Brister, W.S. Beattie, and M.R. Buchanan Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis BMJ 336 2008 195 198
29. Y. Schwammenthal, R. Tsabari, B. Shenkman, R. Schwartz, S. Matetzky, and A. Lubetsky Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome Cerebrovasc Dis 25 2008 355 361
30. S. Ozben, B. Ozben, A.M. Tanrikulu, F. Ozer, and T. Ozben Aspirin resistance in patients with acute ischemic stroke J Neurol 258 2011 1979 1986
31. A.S. Zheng, L. Churilov, R.E. Colley, C. Goh, S.M. Davis, and B. Yan Association of aspirin resistance with increased stroke severity and infarct size JAMA Neurol 70 2013 208 213
32. C. Perneby, N.H. Wallen, C. Rooney, D. Fitzgerald, and P. Hjemdahl Dose- and time-dependent antiplatelet effects of aspirin Thromb Haemost 95 2006 652 658
33. B. Rocca, P. Secchiero, G. Ciabattoni, F.O. Ranelletti, L. Catani, and L. Guidotti Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets Proc Natl Acad Sci U S A 99 2002 7634 7639
34. V. Evangelista, S. Manarini, A. Di Santo, M.L. Capone, E. Ricciotti, and L. Di Francesco De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin Circ Res 98 2006 593 595
35. D. Capodanno, A. Patel, K. Dharmashankar, J.L. Ferreiro, M. Ueno, and M. Kodali Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease Circ Cardiovasc Interv 4 2011 180 187
36. M.T. Santos, A. Moscardo, J. Valles, M. Martinez, M. Pinon, and J. Aznar Participation of tyrosine phosphorylation in cytoskeletal reorganization, alpha(IIb)beta(3) integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets Circulation 102 2000 1924 1930
37. N. Faraday, L.R. Yanek, R. Mathias, J.E. Herrera-Galeano, D. Vaidya, and T.F. Moy Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1 Circulation 115 2007 2490 2496
38. J. Valles, M.T. Santos, J. Aznar, A.J. Marcus, V. Martinez-Sales, and M. Portoles Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment Blood 78 1991 154 162
39. J. Valles, M.T. Santos, J. Aznar, M. Martinez, A. Moscardo, and M. Pinon Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo Blood 99 2002 3978 3984